CFO TribuneCFO Voice ↗
More

Executive record

Edward Stelmakh

Edward Stelmakh is in the CFO seat at OptimizeRx Corporation until a disclosed change takes effect (effective January 1, 2027).

2 verified records · 1 company · current seat on the record: OptimizeRx Corporation

Career line from the records

2

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-08-12TransitionOptimizeRx Corporationcurrent seat

    OptimizeRx Corporation CFO transition: Andrew D’Silva to succeed Edward Stelmakh

    Named as the outgoing officer

    effective January 1, 2027 · 8-K filed August 12, 2026 · sec.gov, Item 5.02

  2. 2026-03-1210-K signatureOptimizeRx Corpcurrent seat

    Signed the annual report as Chief Financial & Strategy Officer (principal financial and accounting officer)

    10-K filed March 12, 2026 · sec.gov

Companies

1

OptimizeRx CorpOPRX

Services-Business Services, NEC

This page lists only verified filing records that name Edward Stelmakh, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.